Events

Summer is here, so we’re treating our members to ice cream for lunch. Choose from five flavours in premium waffle cones or tubs topped with Cadburys flakes, as well as a side table stocked with sprinkles and sauces. Head to the Member of the Future app to RSVP.

​Interactive Networking Panel, live in Hammersmith London, 15 September, 17:30-19:30 GMT   ​The lucrative Life Sciences ecosystems in Lausanne, Switzerland, given the uncertainties elsewhere, provide a set of great and tangible opportunities for UK companies for international growth. At the heart of the Swiss ‘Health Valley’ , an ecosystem gathering 1200+ companies in Pharma, Biotech, […]

The H&F Business Network is a borough-wide stakeholder engagement group consisting of representatives from H&F including business associations, shopping centres, higher education, Federation of Small Businesses (FSB), West London Chambers, Earls Court Development, local banks and other interested business stakeholders and professionals. The group of more than 50 representatives is chaired by Cllr Zarar Qayyum, […]

Clinical Trials, R&D Tax and the Evolving Policy Landscape The life sciences sector continues to play a vital role in driving innovation, attracting investment and delivering advances in healthcare. However, businesses are operating in an increasingly complex environment, balancing growth ambitions with evolving regulation, funding challenges and changing environment priorities. Join Freeths, ARC and BDO for an insightful discussion […]

ARC West London is pleased to be hosting The Future of Women’s Health Summit, a conference taking place as part of National Life Sciences Week 2026. Bringing together leaders and voices from across healthcare, life sciences, technology, government and the wider women’s health sector, the summit will explore some of the most important opportunities and […]

#CreativeDisruption: Breakthrough Oncology Innovation for Start-ups & SMEs, 7 October, 10am-5:30pm Why Attend? Actionable Business Intelligence: Discover new approaches to IP strategy, regulatory pathways, and non-dilutive funding tailored to oncology biotechs. Cross-Sector Collaboration: Connect directly with pharma executives, academic pioneers, and venture capitalists actively seeking investment-ready SME partnerships.Cutting-Edge Research Highlights: Explore disruptive technologies—from AI-driven drug […]